Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 120 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Active Surveillance for Pleomorphic Adenomas of the Parotid-Tumor Growth Rate, Potential Malignancy, and Surgical Sequalae.
Levyn H, Subramanian T, Eagan A, Scholfield DW, Lopez J, Katabi N, Wong RJ, Shah JP, Givi B, Morris LGT, Ganly I, Patel SG
J Surg Oncol, 11 Nov 2024
Cited by: 0 articles | PMID: 39523918
Add to export list
Tumor and Blood B Cell Abundance Outperforms Established Immune Checkpoint Blockade Response Prediction Signatures in Head and Neck Cancer.
Chang TG, Spathis A, Schäffer AA, Gavrielatou N, Kuo F, Jia D, Mukherjee S, Sievers C, Economopoulou P, Anastasiou M, Moutafi M, Pal LR, Vos J, Lee AS, Lam S, Zhao K, Jiang P, Allen CT, Foukas P, [...] Ruppin E
Ann Oncol, S0923-7534(24)04914-7, 15 Nov 2024
Cited by: 0 articles | PMID: 39551185
Add to export list
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort.
Linxweiler M, Wemmert S, Braun FL, Körner S, Brust LA, Knebel M, Klamminger GG, Wagner M, Morris LGT, Kühn JP
Mol Diagn Ther, 01 Nov 2024
Cited by: 0 articles | PMID: 39485665
Add to export list
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas.
Brust LA, Linxweiler M, Schnatmann J, Kühn JP, Knebel M, Braun FL, Wemmert S, Menger MD, Schick B, Holick MF, Kuo F, Morris LGT, Körner S
Biomed Pharmacother, 180:117497, 27 Sep 2024
Cited by: 0 articles | PMID: 39341078
Add to export list
Phase 2 trial of regorafenib in recurrent or metastatic adenoid cystic carcinoma.
Desilets A, Vos JL, Katabi N, Kuo F, Nadeem Z, Linxweiler M, Ostrovnaya I, Baxi S, Dunn LA, Sherman EJ, Pfister DG, Morris LGT, Ho AL
Clin Cancer Res, 01 Oct 2024
Cited by: 0 articles | PMID: 39352719
Add to export list
Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer.
Lee NY, Morris LGT, Diehn M
JAMA Oncol, 10(8):1021-1022, 01 Aug 2024
Cited by: 0 articles | PMID: 38935364
Add to export list
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Zuljan E, von der Emde B, Piwonski I, Afonseca Pestana AC, Klinghammer K, Mock A, Horak P, Heining C, Klauschen F, Pretzell I, Boerries M, Brandts CH, Kreutzfeldt S, Teleanu M, Hübschmann D, Morris LGT, Keller U, Glimm H, Fröhling S, [...] Rieke DT
medRxiv, 13 Jun 2024
Cited by: 0 articles | PPR: PPR867566
Add to export list Preprint
Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines.
Lee J, Han LK, Morris LGT, Korenstein D, Marti JL
J Med Screen, 31(4):263-265, 11 Jun 2024
Cited by: 0 articles | PMID: 38863273
Add to export list
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.
Chang TG, Cao Y, Sfreddo HJ, Dhruba SR, Lee SH, Valero C, Yoo SK, Chowell D, Morris LGT, Ruppin E
Nat Cancer, 5(8):1158-1175, 03 Jun 2024
Cited by: 2 articles | PMID: 38831056
Add to export list
Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma.
Levyn H, Scholfield DW, Eagan A, Boe LA, Shaha AR, Wong RJ, Shah JP, Ganly I, Morris LGT, Tuttle RM
JAMA Otolaryngol Head Neck Surg, 15 May 2024
Cited by: 0 articles | PMID: 38749064
Add to export list
MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J, Fehr A, Jäwert F, Nilsson JA, Morris LGT, Stenman G, Andersson MK
Oral Oncol, 151:106763, 16 Mar 2024
Cited by: 2 articles | PMID: 38493544
Add to export list
RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
Sfreddo HJ, Koh ES, Zhao K, Swartzwelder CE, Untch BR, Marti JL, Roman BR, Dublin J, Wang RS, Xia R, Cohen JM, Xu B, Ghossein R, Givi B, Boyle JO, Tuttle RM, Fagin JA, Wong RJ, Morris LGT
Thyroid, 34(4):450-459, 28 Mar 2024
Cited by: 1 article | PMID: 38407967
Add to export list
A Case Series of Patients With Complex Airway Disease and Large Thyroid Tumors Anterior to the Trachea Precluding Tracheostomy.
Imran S, Chen LL, Rausen M, Morris LGT, Patel S, Halpern NA
Crit Care Explor, 6(2):e1047, 08 Feb 2024
Cited by: 0 articles | PMID: 38343442 | PMCID: PMC10857691
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Lee AS, Valero C, Yoo SK, Vos JL, Chowell D, Morris LGT
Cancers (Basel), 16(1):175, 29 Dec 2023
Cited by: 0 articles | PMID: 38201602 | PMCID: PMC10778506
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Lee NY, Sherman EJ, Schöder H, Wray R, Boyle JO, Singh B, Grkovski M, Paudyal R, Cunningham L, Zhang Z, Hatzoglou V, Katabi N, Diplas BH, Han J, Imber BS, Pham K, Yu Y, Zakeri K, McBride SM, [...] Riaz N
J Clin Oncol, 42(8):940-950, 19 Jan 2024
Cited by: 8 articles | PMID: 38241600
Add to export list
Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.
Levyn H, Subramanian T, Eagan A, Katabi N, Lin O, Badillo ND, Martinez G, Scholfield DW, Wong RJ, Shah JP, Givi B, Morris LGT, Ganly I, Patel SG
JAMA Otolaryngol Head Neck Surg, 149(11):1034-1041, 01 Nov 2023
Cited by: 2 articles | PMID: 37824134 | PMCID: PMC10570915
Add to export list Free full text in Europe PMC
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.
Novoplansky O, Shnerb AB, Marripati D, Jagadeeshan S, Abu Shareb R, Conde-López C, Zorea J, Prasad M, Ben Lulu T, Yegodayev KM, Benafsha C, Li Y, Kong D, Kuo F, Morris LGT, Kurth I, Hess J, Elkabets M
Mol Oncol, 17(12):2618-2636, 31 Aug 2023
Cited by: 4 articles | PMID: 37501404 | PMCID: PMC10701778
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
Oliveira G, Egloff AM, Afeyan AB, Wolff JO, Zeng Z, Chernock RD, Zhou L, Messier C, Lizotte P, Pfaff KL, Stromhaug K, Penter L, Haddad RI, Hanna GJ, Schoenfeld JD, Goguen LA, Annino DJ, Jo V, Oppelt P, [...] Uppaluri R
Sci Immunol, 8(87):eadf4968, 08 Sep 2023
Cited by: 15 articles | PMID: 37683037 | PMCID: PMC10794154
Add to export list Free full text in Europe PMC
Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities.
Ganly I, Kuo F, Makarov V, Dong Y, Ghossein R, Xu B, Morris LGT, Chan TA
Cancer Res Commun, 3(7):1409-1422, 31 Jul 2023
Cited by: 0 articles | PMID: 37529400 | PMCID: PMC10389111
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, [...] Morris LGT
Nat Med, 29(12):3077-3089, 24 Aug 2023
Cited by: 8 articles | PMID: 37620627 | PMCID: PMC11293616
Add to export list Free full text in Europe PMC
Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer.
Morris LGT
Laryngoscope, 134(1):160-165, 30 May 2023
Cited by: 0 articles | PMID: 37249223
Add to export list
Patterns of immune equilibrium and escape in indolent and progressing tumors.
Pandey A, Linxweiler M, Kuo F, Marti JL, Roman B, Ehdaie B, Vos JL, Morris LGT
Cancer Cell, 41(8):1389-1391, 06 Jul 2023
Cited by: 1 article | PMID: 37419120 | PMCID: PMC10849086
Add to export list Free full text in Europe PMC
Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features
Chang T, Cao Y, Sfreddo HJ, Dhruba SR, Lee S, Valero C, Yoo S, Chowell D, Morris LGT, Ruppin E
bioRxiv, 05 Jul 2023
Cited by: 0 articles | PPR: PPR686616
Add to export list Preprint
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.
Knebel M, Körner S, Kühn JP, Wemmert S, Brust L, Smola S, Wagner M, Bohle RM, Morris LGT, Pandey A, Schick B, Linxweiler M
Front Immunol, 14:1172768, 13 Jun 2023
Cited by: 3 articles | PMID: 37383237 | PMCID: PMC10294051
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.
Boucai L, Saqcena M, Kuo F, Grewal RK, Socci N, Knauf JA, Krishnamoorthy GP, Ryder M, Ho AL, Ghossein RA, Morris LGT, Seshan V, Fagin JA
Clin Cancer Res, 29(8):1620-1630, 01 Apr 2023
Cited by: 13 articles | PMID: 36780190 | PMCID: PMC10106408
Add to export list Free full text in Europe PMC

1-25 of 120 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Active Surveillance for Pleomorphic Adenomas of the Parotid-Tumor Growth Rate, Potential Malignancy, and Surgical Sequalae.

Tumor and Blood B Cell Abundance Outperforms Established Immune Checkpoint Blockade Response Prediction Signatures in Head and Neck Cancer.

Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort.

Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas.

Phase 2 trial of regorafenib in recurrent or metastatic adenoid cystic carcinoma.

Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer.

Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer

Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines.

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.

Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma.

MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.

RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.

A Case Series of Patients With Complex Airway Disease and Large Thyroid Tumors Anterior to the Trachea Precluding Tracheostomy.

Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.

Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.

Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.

Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities.

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.

Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer.

Patterns of immune equilibrium and escape in indolent and progressing tumors.

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.

Partnerships & funding